Pharmafile Logo

FDA Map

FDAMAP is a group of global healthcare experts that conducts highly informative conferences, workshops and other training sessions for pharma, diagnostics and medical device industry professionals. Our panels of speakers include experts in clinical trials, data management, statistics, regulatory affairs, safety reporting, pharmacovigilance, social media marketing of medical products (drugs, biologics and medical devices), project management, GMP, GCP GLP, FDA/EMA audits, and information technology. Learn more about our Training and Consultancy Programs (Regulatory Workshops, FDA Seminars and Conferences, and Regulatory Consultancy) on our website www.fdamap.com

We work with professionals, regulators, and government agencies to build unique platforms for consultation, training, networking, and professional development. We strive hard to make high quality, mutually beneficial relationships with our customers and partners alike.

The FDAMap initiative is the newest venture of a group of leading experts from the industry and government to bring professionals at all levels together to create best practices based on logic, logistics, legal, and least-burdensome compliance. Visit: www.fdamap.com

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

20203 Goshen Rd,, Suite 261 Gaithersburg, Gaithersburg, Maryland, MD 20879, United States
+1-410-501-5777

 Latest Content from PMHub 

The Pharma UK Twitter Ranking 2018 [RESEARCH]

The second edition in our Pharma Social Media Series, the UK Twitter Ranking.

Trending: using social media to understand your pharma market

Blue Latitude Health Senior Associate Consultant Jiayi Chen explains how you can use social media to get under the skin of customers and your competition.

SWITCHED ONcology

We bring together the experts. The patients. The scientists. The technologists. The creatives. We unite powerful insights to make science mean something real. We are stronger together. We are Switched...

PEGASUS SCOOPS TWO AWARDS AT COMMUNIQUÉ 2018 FOR ITS ‘SMALL TALK SAVES LIVES’ CAMPAIGN

Press Releases | July 3, 2018 | Inizio

Pegasus was also highly commended for Communiqué Agency of the Year 2018Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the Excellence In Public Health...

18 SWITCHED ONcology: The Big Communication

Matching unprecedented clinical advances in immuno-oncology with transformative communication

Porterhouse Medical launches new website showcasing the latest exciting developments within the group.

Porterhouse Medical Group is thrilled to launch a new website (www.porterhousemedical.com) highlighting the expansion of the group over the past 6 months, developments that have seen the addition of a suite...

Lucid’s magic touch is recognised, winning both Communiqué Medical Education Consultancy of the Year and Communiqué Communications Consultancy of the Year 2018

Lucid’s pioneering and patient-centric approach to strategic medical communications was recognised yesterday as they scooped  a total of four awards. These included: Excellence in Communications via Meetings for OptiMiSe –...

Wilmington Healthcare appoints new Commercial Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.

What pharma marketers can learn from growth hacking?

Growth hackers instinctively blend technical skills with creative thinking

The Challenges Of UX In Healthcare: Technology To Change Lives

Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today.